Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) were up 14.3% on Tuesday . The stock traded as high as C$0.24 and last traded at C$0.24. Approximately 450,853 shares changed hands during mid-day trading, a decline of 2% from the average daily volume of 458,386 shares. The stock had previously closed at C$0.21.
Voyageur Pharmaceuticals Price Performance
The stock has a market cap of C$33.47 million, a P/E ratio of -24.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The business has a 50 day simple moving average of C$0.10 and a 200-day simple moving average of C$0.07.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- How Investors Can Find the Best Cheap Dividend Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- ETF Screener: Uses and Step-by-Step Guide
- What Does the Future Hold for Eli Lilly?
- Compound Interest and Why It Matters When Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
